HIV Infections, Substance Use
Conditions
Brief summary
This study utilizes a randomized controlled trial design to evaluate the efficacy of couples motivational interviewing (MI) to reduce the frequency and severity of illicit drug use and frequency of HIV transmission risk behavior (TRB). Participants are randomized to one of two conditions: couples MI or standard couples HIV testing and counseling (CHTC).
Interventions
BEHAVIORALCouples Health Project
A 3-session, couples motivational Interviewing drug use and HIV risk reduction intervention
Sponsors
Hunter College of City University of New York
National Institute on Drug Abuse (NIDA)
Study design
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Intervention model description
This study utilizes a randomized controlled trial design to evaluate the efficacy of couples motivational interviewing (MI) to reduce the frequency and severity of illicit drug use and frequency of HIV transmission risk behavior (TRB). Participants are randomized to one of two conditions: couples MI or standard couples HIV testing and counseling (CHTC).
Eligibility
Sex/Gender
MALE
Age
18 Years to 55 Years
Healthy volunteers
Yes
Inclusion criteria
* Have a main partner who is another cisgender male and have been in a relationship for 3 month or longer * Index participant must be between 18 and 55; Main partner can be any age 18 and older * One participant must be HIV negative (as confirmed by rapid test) * One participant must have used at least 1 drug in the past 30 days (cocaine/crack, opiates, misuse of prescription medication, stimulants, psychedelics, ecstasy, ketamine, GHB, amyl nitrite) * Index participant must have engaged in TRB in the past 30 days- Defined as CAS with a casual partner, or a serodiscordant or non-monogamous main partner * Live in the United States * Speak and read English
Exclusion criteria
* Any signs of serious mental illness or cognitive deficit * Current suicidal/homicidal ideations * History of IPV with their main partner and safety concerns in the current relationship.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Drug use Frequency | 9 Months | Number of reported days of illicit drug use (amphetamines, cocaine/crack, GHB, ketamine or ecstasy) reported on quarterly timeline follow-back assessments |
| Urine assay for drug use | 9 Months | Positive urine screen for drug use assessed bi-annually |
| CAS with casual partners | 9 Months | Number of total anal sex acts (insertive and receptive) with casual partners reported on quarterly timeline follow-back assessments in the absence of adequate PrEP coverage |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Bacterial sexually transmitted infections | 9 Months | Any chlamydia or gonorrhea diagnosis |
| Binge Drinking | 9 Months | Number of days on which 5 or more drinks containing alcohol were reported on the quarterly timeline follow-back interview |
| PrEP Uptake | 9 months | self-reported receipt of a PrEP-prescription |
Countries
United States
Contacts
CONTACTTyrel J Starks, PHD
CONTACTDemetria Cain, PHD
Outcome results
None listed